267 related articles for article (PubMed ID: 16197870)
1. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
[TBL] [Abstract][Full Text] [Related]
2. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
3. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
4. Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?
Irfan S; Jabeen K; Jilani UA; Ahmed B; Mehraj J; Ahsan T; Zafar A
J Infect Dev Ctries; 2012 Oct; 6(10):700-3. PubMed ID: 23103891
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
6. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
Ray P; Sharma J; Marak RS; Garg RK
Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
[TBL] [Abstract][Full Text] [Related]
7. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi.
Kapil A; Renuka ; Das B
Indian J Med Res; 2002 Feb; 115():49-54. PubMed ID: 12138664
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
[TBL] [Abstract][Full Text] [Related]
9. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
10. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Crump JA; Barrett TJ; Nelson JT; Angulo FJ
Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
Joshi S; Amarnath SK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
[TBL] [Abstract][Full Text] [Related]
13. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
14. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
15. Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal.
Acharya D; Bhatta DR; Malla S; Dumre SP; Adhikari N; Kandel BP
Nepal Med Coll J; 2011 Jun; 13(2):69-73. PubMed ID: 22364084
[TBL] [Abstract][Full Text] [Related]
16. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
17. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
18. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
[TBL] [Abstract][Full Text] [Related]
19. Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation.
Acharya D; Malla S; Bhatta DR; Adhikari N; Dumre SP
Kathmandu Univ Med J (KUMJ); 2012; 10(37):24-9. PubMed ID: 22971857
[TBL] [Abstract][Full Text] [Related]
20. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
